Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice. - Wikidata - wikimedia - TriplyDB

Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice.

Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice.

http://www.wikidata.org/entity/Q36068878

about

Sanfilippo syndrome: causes, consequences, and treatments Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III).Neurodevelopmental Changes in Excitatory Synaptic Structure and Function in the Cerebral Cortex of Sanfilippo Syndrome IIIA Mice Heparan sulfate 3-O-sulfation: a rare modification in search of a function.Hs3st3-modified heparan sulfate controls KIT+ progenitor expansion by regulating 3-O-sulfotransferases A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis.Glycan-based biomarkers for mucopolysaccharidoses.Lysosomal diseases: diagnostic update.The function of heparan sulfate during branching morphogenesis.Unmet Needs in Dystonia: Genetics and Molecular Biology-How Many Dystonias?Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations.GM2 Gangliosidosis in Shiba Inu Dogs with an In-Frame Deletion in HEXB.Arylsulfatase K, a novel lysosomal sulfatase.Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity.Genome-wide association study in musician's dystonia: a risk variant at the arylsulfatase G locus?Arylsulfatase K is the Lysosomal 2-Sulfoglucuronate Sulfatase.A homozygous founder missense variant in arylsulfatase G abolishes its enzymatic activity causing atypical Usher syndrome in humans.Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.The Chihuahua dog: A new animal model for neuronal ceroid lipofuscinosis CLN7 disease?

P2860

Q26773200-05A954CB-99FC-43BA-A7F5-59B02E9E5073 Q27301077-EB01D11F-94FC-4F57-9941-0F719CDE4DEA Q33572735-0026BD91-B579-4C5F-900D-0E5B4CF56136 Q33690545-02E9A262-26AE-46B5-9A8D-CC79848A92A7 Q33927015-C3687FA2-45B9-4CE1-A7F1-1D42F4AFC402 Q35536486-48CEDABD-C84C-465D-95BE-E16D7411A639 Q37161285-212AFA31-5148-4AA0-B292-FECE2EB1057F Q38202920-2241CFEC-855E-4A43-A1EE-9D6BC183BEAB Q38949781-6CE493B7-9298-4682-9597-446047F2F89F Q39110426-028B2621-4E74-4B6B-A4A9-EBDAD23C333F Q39552940-0FA9DC6D-A7D8-478E-ABEA-6CA95B8123CB Q42358915-2723DD7C-EA2D-4658-92B0-86C1D7E1DA32 Q42771926-8E30EFB0-BBE9-4867-8564-D87DDE84A3CE Q42926827-AE9324A1-F42A-48EE-ADBD-E6CE875C9B9D Q44248875-62052890-41DD-488A-9F4F-38F418133256 Q46018872-69CE1B2D-9BE1-4AD7-AF31-70FA2C0ABA0C Q47233072-CE590300-9F11-41A4-A81E-F959D7D03B24 Q47786937-C8029E19-5EDF-4603-AFBB-2526DE214F48 Q52144841-69D44961-0CEF-4A6F-B132-CB8757FAF659

P2860

Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice.

http://www.wikidata.org/entity/Q36068878

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Arylsulfatase G inactivation c ...... mucopolysaccharidosis in mice.

@ast

Arylsulfatase G inactivation c ...... mucopolysaccharidosis in mice.

@en

type

label

Arylsulfatase G inactivation c ...... mucopolysaccharidosis in mice.

@ast

Arylsulfatase G inactivation c ...... mucopolysaccharidosis in mice.

@en

prefLabel

Arylsulfatase G inactivation c ...... mucopolysaccharidosis in mice.

@ast

Arylsulfatase G inactivation c ...... mucopolysaccharidosis in mice.

@en

P1433

Q36068878-79040F27-40C3-4641-B99E-ECDF7003373D

P1476

Q36068878-CADFC49F-B887-412F-8659-28FB6D32A2DC

P2093

Q36068878-277921A7-FAD9-4C41-8225-FCD73F0E2714

Q36068878-5092034B-99A1-40E1-BA17-BE5F03680FCE

Q36068878-5AB0F3A0-E904-4985-9ABC-9CC24B457D2D

Q36068878-5FECAAE0-0A96-4BF9-A305-6694545A9FF6

Q36068878-637B4D40-6D1E-43F7-84F0-009A5975B23D

Q36068878-7435A0E1-E82D-450F-9D89-F0E280A12B75

Q36068878-8913326B-43EF-4C53-8714-E012642A540F

Q36068878-9E4E9EEB-3F97-4D19-87C3-7AFCE2415D39

Q36068878-A7A4C204-4D82-4AFF-8423-502491D37990

Q36068878-AE5808BC-A5DF-4396-86F7-EA39EC54C5B9

P2860

Q36068878-0B26A594-A686-4276-B0EB-DD242674960E

Q36068878-101F674A-415C-4ED8-B533-D88B5BF50106

Q36068878-15D9543D-BC04-42AD-B9BF-BA0AD0AFC021

Q36068878-161FD34A-D403-4C93-99EB-F25E0DFB3F19

Q36068878-1CE0447B-77A6-42D1-9DAE-A8BF7251DB19

Q36068878-1CECFF40-D0EB-4BC7-ACDF-E19561CBAFD1

Q36068878-3D60940B-7CAD-4F12-987D-2535C0BE58AE

Q36068878-477686A6-5619-4018-8757-66EB5AC2A8A3

Q36068878-4E75E17A-6408-4416-96D6-00EF5F6D74F6

Q36068878-5D9A46F8-70BF-4500-9B0D-B5C98B7BC2FB

P304

Q36068878-3835BE4B-80E3-4435-A053-EA25A10BE549

P31

Q36068878-F90A962E-EDF9-43DB-958F-48638D32899B

P356

Q36068878-65CA4FEE-F4D6-4DC0-A160-CF6ED2DB89E5

P407

Q36068878-2A059ED8-74FB-4EDA-950B-BC02452EE097

P433

Q36068878-D61B7AA6-7FCA-4D24-81A7-AF1412CF556D

P478

Q36068878-B3E554B0-C01E-4A4F-A7A6-466325B2D144

P50

Q36068878-CF516078-FCF4-4AE1-B609-AD2EC59F332D

P577

Q36068878-CE29A91E-ECA0-49E7-9859-92B07197C4FD

P5875

Q36068878-9EEFCA4A-685C-495F-A9D4-B174DCEF0029

P698

Q36068878-1C09904F-F557-44A7-B7D8-4186FB0481B0

P932

Q36068878-4F994417-A851-4F62-89C0-35C21DB7500F

P356

PNAS.1202071109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Arylsulfatase G inactivation c ...... mucopolysaccharidosis in mice.

@en

P2093

Björn Kowalewski

http://www.w3.org/2001/XMLSchema#string

Ina Kalus

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Esko

http://www.w3.org/2001/XMLSchema#string

Marc-André Frese

http://www.w3.org/2001/XMLSchema#string

Markus Damme

http://www.w3.org/2001/XMLSchema#string

Michael Padva

http://www.w3.org/2001/XMLSchema#string

Renate Lüllmann-Rauch

http://www.w3.org/2001/XMLSchema#string

Roger Lawrence

http://www.w3.org/2001/XMLSchema#string

Rudi D'Hooge

http://www.w3.org/2001/XMLSchema#string

Stijn Stroobants

http://www.w3.org/2001/XMLSchema#string

P2860

Arylsulfatase G, a novel lysosomal sulfatase

Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase

Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues

A sulfatase specific for glucuronic acid 2-sulfate residues in glycosaminoglycans

A novel 3-O sulfatase from human urine acting on methyl-2-deoxy-2-sulfamino-alphs-D-glucopyranoside 3-sulfate

Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis

Order out of chaos: assembly of ligand binding sites in heparan sulfate

A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis.

Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.

Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D.

P304

10310-10315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1202071109

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Renate Lüllmann-Rauch

P577

2012-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225293777

http://www.w3.org/2001/XMLSchema#string

P698

22689975

http://www.w3.org/2001/XMLSchema#string

P932

3387061

http://www.w3.org/2001/XMLSchema#string